Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Dovish Fed lifts Wall Street stock futures to record high

Thu, 08th Apr 2021 12:57

* S&P stock futures hit record highs

* European shares at record levels

* Crude oil slips after rise in U.S. gasoline stocks

* Fed's Powell to speak at IMF event at 1600 GMT

* Weekly U.S. jobless claims data due at 1230 GMT

* ECB reassures on accommodative monetary policy

By Huw Jones

LONDON, April 8 (Reuters) - Wall Street was poised to notch
a record high on Thursday after reassurance from the Federal
Reserve that its bond-buying support for economic recovery won't
be ending anytime soon.

E-mini futures on the S&P 500 were up 0.33% at 4,083
points, just off a record high of 4,092.75 earlier. Nasdaq
futures gained 0.86%

Minutes of the Fed's last policy meeting, published on
Wednesday, showed members felt the economy was still short of
target and were in no rush to scale back their $120 billion a
month of bond buying.

"As long as that message remains consistent and, more
importantly, unified, that is going to have a bigger and bigger
influence on yields," said Derek Halpenny, head of research for
global markets at MUFG.

"That is what is key in the market at the moment, as rates
appear to have reached some degree of equilibrium, and that is
what is encouraging the equities market performance. I can't
really see anything on the immediate horizon to upset that."

U.S. Treasuries yields were down from their
14-month highs, although analysts said markets will be tested
next week when the U.S. earnings seasons gets underway.

The U.S. weekly jobless claims data is due at 1230 GMT, and
is expected to show the number of Americans filing for new
unemployment benefits dropped in the latest week, a further sign
the economy is recovering from COVID-19.

Fed Chairman Jerome Powell speaks at 1600 GMT at an
International Monetary Fund event and he is likely to reiterate
the dovish outlook.

There was little in the way of corporate news, though shares
in Tesla Inc rose about 1% after President Joe Biden's
administration proposed a $174 billion boost to electric
vehicles.

ECB DOVISH TOO

Stocks in Europe also reached record highs, buoyed by
optimism in Britain over easing lockdown restrictions and
supportive outlooks from the Fed and the European Central Bank.

The European STOXX index of 600 leading companies
rose 0.44%, just off the high of 436.66 points it reached
earlier in the session. London's blue-chip FTSE 100 index
was up 0.4%.

"It's looking good as evaluations in Europe are much lower
than they are in the U.S., so there is potentially more upside.
The line of least resistance for European markets is higher,"
said Michael Hewson, chief market analyst at CMC Markets.

"In terms of economic re-opening, there is enough optimism
built in at the moment to drive markets quite a bit higher from
here, and the Fed has reiterated it's going to remain on hold
for a while," Hewson said.

The ECB said in the account of its March 11 meeting,
published on Thursday, that it was important to provide
reassurance there would be no change in its accommodative
monetary policy for as long as necessary.

In Asia, MSCI's broadest index of Asia-Pacific shares
outside Japan inched up 0.3% in quiet trade.
Japan's Nikkei slipped 0.3%, not helped by news Tokyo's
governor had asked for emergency measures to stem a surge of
COVID-19 infections.

In currencies, the dollar index eased to 92.291 from
its recent five-month high at 93.439.

The euro was steady at $1.1877, after rising as high
as $1.1914 overnight following a surprisingly upbeat survey of
European Union business activity.

In commodity markets, gold was at $1,750 an ounce.

Oil prices fell after official figures showed a big
increase in U.S. gasoline stockpiles, causing concern about
demand for crude weakening in the world's biggest consumer of
the resource at a time when supplies around the world are
rising.

Brent fell 29 cents to $62.87 a barrel. U.S. crude
lost 44 cents to $59.33 per barrel.

(Aditional reporting by Wayne Cole and Chibuike Oguh; editing
by Larry King)

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.